0001179929-26-000005
SEC filingMolina Healthcare's 2025 Notes show $1B buybacks, $850M new debt, and 5.5M members served across four segments.
Molina Healthcare, Inc. is a FORTUNE 500 company that provides managed healthcare services under government-sponsored programs, primarily Medicaid and Medicare, and through state insurance marketplaces. Founded in 1980 and reincorporated in Delaware in 2002, the company served approximately 5.5 million members across 21 states as of December 31, 2025. Its mission is to improve the health and lives of its members by delivering high-quality healthcare.
Molina operates four reportable segments: Medicaid, Medicare, Marketplace, and Other. The Medicaid segment generated $32.2 billion in premium revenue in 2025, representing 75% of consolidated premium revenue. It serves low-income populations through programs such as TANF, ABD, CHIP, Medicaid Expansion, and LTSS. The Medicare segment contributed $6.2 billion (14.5%) through Medicare Advantage plans including MAPD, D-SNP, HIDE, FIDE, CO D-SNP, C-SNP, and MMP. The Marketplace segment accounted for $4.5 billion (10.4%) via ACA-compliant plans on federal and state-based exchanges. The Other segment, including LTSS consultative services and the ConnectiCare commercial business, was insignificant at $90 million.
Molina's products are government-sponsored health plans: Medicaid managed care, Medicare Advantage (MAPD), dual-eligible special needs plans (D-SNP, HIDE, FIDE, CO D-SNP), chronic special needs plans (C-SNP), Medicare-Medicaid Plans (MMP), and Marketplace insurance plans. These products are designed for low-income and dual-eligible populations, emphasizing coordinated care and cost management.
Molina contracts with state and federal governments through formal bid processes (RFPs) for Medicaid and Medicare, and annually certifies Marketplace plans with CMS or state regulators. Member enrollment is driven by auto-assignment, insurance agents, direct marketing, and exchanges. Significant customer concentration exists in four states: California, New York, Texas, and Washington each accounted for at least 10% of Medicaid premium revenue in 2025. The loss of any major contract could materially affect results.
The managed care industry is highly competitive. In Medicaid, Molina competes with Centene, CVS Health (Aetna), Elevance Health, UnitedHealth, and large not-for-profits. In Medicare, key competitors include Humana, UnitedHealth, and CVS Health. For Marketplace, Centene is the primary competitor for low-income subsidized members. Competition centers on provider networks, quality ratings, pricing, and service.
Molina’s long-term strategy is to remain a pure-play government-sponsored healthcare business. Key pillars include: growing organically and through acquisitions, providing low-cost health plans, delivering high-quality care with appropriate access, offering reliable service, and returning excess capital through share repurchases. The company targets 11%-13% long-term premium revenue and net income growth, aiming to surpass $50 billion in premium revenue by 2027. It emphasizes medical cost management via care management, value-based contracting, and AI investments.
As of December 31, 2025, Molina employed approximately 19,000 people. The company focuses on employee development, leadership programs, and market-competitive total rewards including health insurance, 401(k) matching, paid parental leave, and wellness programs. Annual engagement surveys show high levels of employee engagement exceeding industry benchmarks.
As of December 31, 2025, the company held $4.248B in cash and cash equivalents plus $4.008B in current investments, totaling $8.256B in highly liquid assets. Restricted investments of $299M are held for regulatory purposes. Total debt stood at $3.766B, consisting of multiple senior notes with maturities from 2028 to 2033. The debt-to-equity ratio was 0.93x. Medical claims and benefits payable of $4.887B represent the largest liability, with IBNP claims of $3.211B.
The Notes do not disclose material purchase commitments beyond lease obligations. Operating lease liabilities total $71M and finance leases $209M. The company is involved in a securities class action and derivative suit, but no loss estimate is provided. Regulatory capital requirements mandate aggregate statutory capital of $3.1B, and the company held $4.6B in excess.
In 2025, Molina repurchased $1.0B of common stock (4.528M shares) under two authorizations: $500M in Q1 at $297.83/sh and $500M in Q3 at $175.50/sh. A new $1B authorization was approved in April 2025 extending through 2026. No dividends were paid. Debt activity included the issuance of $850M 6.5% Notes due 2031, with proceeds used to repay $740M in term loans, plus $150M in other short-term borrowings. Capital expenditures (noted in cash flow but not in Notes) were $101M for property and software.
The Medicaid segment generated $32.240B in premium revenue (74.8% of total), with a medical margin of $2.652B (8.2% margin). Medicare delivered $6.235B in premiums (14.5%), margin $475M (7.6%). Marketplace surged to $4.487B (10.4%), margin $423M (9.4%). The Other segment contributed $90M in premiums. Key geographic concentrations: California (10% of premium), Texas (13%), Washington (10%). The company served 5.5 million members across 21 states.
No cash flow data is available in the provided document excerpt. The filing includes reference to the Consolidated Statements of Cash Flows on page 59, but the actual numbers are not included in the input. Therefore, analysis of CFO vs Net Income, capex intensity, free cash flow, or capital returns is not possible. Please provide the full cash flow statement for further analysis.